These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17101928)

  • 1. Maintaining adherence and retention in dementia prevention trials.
    DeKosky ST
    Neurology; 2006 Nov; 67(9 Suppl 3):S14-6. PubMed ID: 17101928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary prevention trials in Alzheimer disease.
    Green RC; DeKosky ST
    Neurology; 2006 Nov; 67(9 Suppl 3):S2-5. PubMed ID: 17101930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention trials in Alzheimer disease: one step forward?
    Touchon J; Portet F; Gauthier S
    Neurology; 2006 Nov; 67(9 Suppl 3):S21-2. PubMed ID: 17101931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dropouts and refusals in observational studies: lessons for prevention trials.
    Jacova C; Hsiung GY; Feldman HH
    Neurology; 2006 Nov; 67(9 Suppl 3):S17-20. PubMed ID: 17101929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of Alzheimer disease.
    Thal LJ
    Alzheimer Dis Assoc Disord; 2006; 20(3 Suppl 2):S97-9. PubMed ID: 16917204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia.
    DeKosky ST; Fitzpatrick A; Ives DG; Saxton J; Williamson J; Lopez OL; Burke G; Fried L; Kuller LH; Robbins J; Tracy R; Woolard N; Dunn L; Kronmal R; Nahin R; Furberg C;
    Contemp Clin Trials; 2006 Jun; 27(3):238-53. PubMed ID: 16627007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADCS Prevention Instrument Project: overview and initial results.
    Ferris SH; Aisen PS; Cummings J; Galasko D; Salmon DP; Schneider L; Sano M; Whitehouse PJ; Edland S; Thal LJ;
    Alzheimer Dis Assoc Disord; 2006; 20(4 Suppl 3):S109-23. PubMed ID: 17135805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.
    Zandi PP; Sparks DL; Khachaturian AS; Tschanz J; Norton M; Steinberg M; Welsh-Bohmer KA; Breitner JC;
    Arch Gen Psychiatry; 2005 Feb; 62(2):217-24. PubMed ID: 15699299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADCS Prevention Instrument Project: behavioral measures in primary prevention trials.
    Cummings JL; Raman R; Ernstrom K; Salmon D; Ferris SH;
    Alzheimer Dis Assoc Disord; 2006; 20(4 Suppl 3):S147-51. PubMed ID: 17135808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADCS Prevention Instrument Project: the Mail-In Cognitive Function Screening Instrument (MCFSI).
    Walsh SP; Raman R; Jones KB; Aisen PS;
    Alzheimer Dis Assoc Disord; 2006; 20(4 Suppl 3):S170-8. PubMed ID: 17135810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of Alzheimer's Disease: Lessons Learned and Applied.
    Galvin JE
    J Am Geriatr Soc; 2017 Oct; 65(10):2128-2133. PubMed ID: 28766695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing cognitive decline in preclinical Alzheimer's disease.
    Riedel WJ
    Curr Opin Pharmacol; 2014 Feb; 14():18-22. PubMed ID: 24565007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methodological challenges in designing dementia prevention trials - the European Dementia Prevention Initiative (EDPI).
    Richard E; Andrieu S; Solomon A; Mangialasche F; Ahtiluoto S; Moll van Charante EP; Coley N; Fratiglioni L; Neely AS; Vellas B; van Gool WA; Kivipelto M
    J Neurol Sci; 2012 Nov; 322(1-2):64-70. PubMed ID: 22818266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADCS Prevention Instrument Project: ADCS-clinicians' global impression of change scales (ADCS-CGIC), self-rated and study partner-rated versions.
    Schneider LS; Clark CM; Doody R; Ferris SH; Morris JC; Raman R; Reisberg B; Schmitt FA
    Alzheimer Dis Assoc Disord; 2006; 20(4 Suppl 3):S124-38. PubMed ID: 17135806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Thal LJ; Carta A; Doody R; Leber P; Mohs R; Schneider L; Shimohama S; Silber C
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():46-9. PubMed ID: 9305516
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential prevention of Alzheimer disease and dementia.
    Kuller LH
    Alzheimer Dis Assoc Disord; 1996; 10 Suppl 1():13-6. PubMed ID: 8876782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methodological issues in primary prevention trials for neurodegenerative dementia.
    Andrieu S; Coley N; Aisen P; Carrillo MC; DeKosky S; Durga J; Fillit H; Frisoni GB; Froelich L; Gauthier S; Jones R; Jönsson L; Khachaturian Z; Morris JC; Orgogozo JM; Ousset PJ; Robert P; Salmon E; Sampaio C; Verhey F; Wilcock G; Vellas B
    J Alzheimers Dis; 2009; 16(2):235-70. PubMed ID: 19221415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins for the prevention of dementia.
    McGuinness B; Craig D; Bullock R; Passmore P
    Cochrane Database Syst Rev; 2009 Apr; (2):CD003160. PubMed ID: 19370582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and Functional Decline in Patients With Mild Alzheimer Dementia With or Without Comorbid Diabetes.
    Ascher-Svanum H; Chen YF; Hake A; Kahle-Wrobleski K; Schuster D; Kendall D; Heine RJ
    Clin Ther; 2015 Jun; 37(6):1195-205. PubMed ID: 25676448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diet and Alzheimer's disease risk factors or prevention: the current evidence.
    Solfrizzi V; Panza F; Frisardi V; Seripa D; Logroscino G; Imbimbo BP; Pilotto A
    Expert Rev Neurother; 2011 May; 11(5):677-708. PubMed ID: 21539488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.